Loading organizations...
Loading organizations...
Key people at Livzon Pharmaceutical Group.
Key people at Livzon Pharmaceutical Group.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 5, 2022 | Atom Bioscience & Pharmaceutical | $45.0M Series C | Yuhang Teng, Huang Pu | Efung Capital, Hongshan Capital Group (Sequoia Capital China), Kaitai Capital, Unifortune Investment Holdings Group |
| Oct 2, 2019 | Elicio Therapeutics | $33.0M Series B | — | Efung Capital |
| Jun 17, 2015 | LungLife AI | $25.5M Series B | Tao Desheng | Greenwoods, Syno Capital |
| Apr 16, 2014 | Epirus Biopharmaceuticals | $36.0M Series B | Daotian Fu | 5AM Ventures, Adage Capital Management, Gibralt US, Greenwoods Investment, Monashee Investment Management, Montreux Equity Partners, Mousse Partners, TPG Biotech |